Physiological roles of muscle-derived interleukin-6 in response to exercise

Current Opinion in Clinical Nutrition and Metabolic Care

Volumn 10, Issue 3, 2007, Pages 265-271

  Pedersen, Bente K ^a,b   Fischer, Christian P ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b Rigshospitalet   (Denmark)

Author keywords

Adipose tissue; Cytokines; Insulin resistance; Interleukins; Skeletal muscle; Type 2 diabetes

Indexed keywords

HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; INSULIN; INTERLEUKIN 6; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE; REACTIVE OXYGEN METABOLITE; SUPPRESSOR OF CYTOKINE SIGNALING 3; TRANSCRIPTION FACTOR; TUMOR NECROSIS FACTOR ALPHA;

ADAPTATION; ANTIINFLAMMATORY ACTIVITY; CALCIUM HOMEOSTASIS; CHRONIC DISEASE; CYTOKINE PRODUCTION; DYNAMIC EXERCISE; ENZYME ACTIVATION; GENE EXPRESSION REGULATION; GLUCOSE METABOLISM; GLUCOSE TRANSPORT; HORMONAL REGULATION; HUMAN; IMPAIRED GLUCOSE TOLERANCE; LIPID OXIDATION; LIPOLYSIS; METABOLIC REGULATION; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OBESITY; PHYSIOLOGY; REGULATORY MECHANISM; REVIEW; SKELETAL MUSCLE; UPREGULATION;

ADAPTATION, PHYSIOLOGICAL; EXERCISE; HUMANS; INTERLEUKIN-6; MUSCLE CONTRACTION; MUSCLE, SKELETAL;

EID: 34247130827     PISSN: 13631950     EISSN: 15353885     Source Type: Journal    
DOI: 10.1097/MCO.0b013e3280ebb5b3     Document Type: Review

References (100)

1. Steensberg A, Van Hall G, Osada T, et al. Production of interleukin-6 in contracting human skeletal muscles can account for the exercise-induced increase in plasma interleukin-6. J Physiol 2000; 529:237-242.
2. Gleeson M. Interleukins and exercise. J Physiol 2000; 529:1.
3. Pedersen BK, Hoffman-Goetz L. Exercise and the immune system: regulation, integration and adaption. Physiol Rev 2000; 80:1055-1081.
4. Febbraio MA, Pedersen BK. Muscle-derived interleukin-6: mechanisms for activation and possible biological roles. FASEB J 2002; 16:1335-1347.
5. Pedersen BK, Steensberg A, Fischer C, et al. Searching for the exercise factor - is IL-6 a candidate. J Muscle Res Cell Motil 2003; 24:113-119.
6. Pedersen BK. The anti-inflammatory effect of exercise: its role in diabetes and cardiovascular disease control. Essays Biochem 2006; 42:105-117.
7. Pedersen BK, Febbraio M. Muscle-derived interleukin-6: a possible link between skeletal muscle, adipose tissue, liver, and brain. Brain Behav Immun 2005; 19:371-376.
8. Febbraio MA, Pedersen BK. Contraction-induced myokine production and release: is skeletal muscle an endocrine organ? Exerc Sport Sci Rev 2005; 33:114-119.
9. Petersen AM, Pedersen BK. The anti-inflammatory effect of exercise. J Appl Physiol 2005; 98:1154-1162.
10. Suzuki K, Nakaji S, Yamada M, et al. Systemic inflammatory response to exhaustive exercise. Cytokine kinetics. Exerc Immunol Rev 2002; 8:6-48.
11. Toft AD, Jensen LB, Bruunsgaard H, et al. Cytokine response to eccentric exercise in young and elderly humans. Am J Physiol Cell Physiol 2002; 283:C289-C295.
12. Bruunsgaard H, Galbo H, Halkjaer-Kristensen J, et al. Exercise-induced increase in interleukin-6 is related to muscle damage. J Physiol 1997; 499:833-841.
13. Ostrowski K, Schjerling P, Pedersen BK. Physical activity and plasma interleukin-6 in humans - effect of intensity of exercise. Eur J Appl Physiol 2000; 83:512-515.
14. Fischer CP, Hiscock N, Basu S, et al. Supplementation with vitamins C and E inhibits the release of interleukin-6 from contracting human skeletal muscle. J Physiol 2004; 558:633-645.
15. Bergfors M, Barnekow-Bergkvist M, Kalezic N, et al. Short-term effects of repetitive arm work and dynamic exercise on glucose metabolism and insulin sensitivity. Acta Physiol Scand 2005; 183:345-356.
16. Hirose L, Nosaka K, Newton M, et al. Changes in inflammatory mediators following eccentric exercise of the elbow flexors. Exerc Immunol Rev 2004; 10:75-90.
17. Fischer CP. Interleukin-6 in acute exercise and training: what is the biological relevance. Exerc Immunol Rev 2006; 12:6-33.
18. Nielsen HB, Secher N, Perdersen BK. Lymphocytes and NK cell activity during repeated bouts of maximal exercise. Am J Physiol 1996; 271:R222-R227.
19. Ostrowski K, Rohde T, Asp S, et al. Pro- and anti-inflammatory cytokine balance in strenuous exercise in humans. J Physiol 1999; 515:287-291.
20. Ostrowski K, Rohde T, Zacho M, et al. Evidence that IL-6 is produced in skeletal muscle during prolonged running. J Physiol 1998; 508:949-953.
21. Steensberg A, Febbraio MA, Osada T, et al. Interleukin-6 production in contracting human skeletal muscle is influenced by preexercise muscle glycogen content. J Physiol 2001; 537:633-639.
22. Hiscock N, Chan MH, Bisucci T, et al. Skeletal myocytes are a source of interleukin-6 mRNA expression and protein release during contraction: evidence of fiber type specificity. FASEB J 2004; 18:992-994.
23. Steensberg A, Keller C, Starkie RL, et al. IL-6 and TNF-alpha expression in, and release from, contracting human skeletal muscle. Am J Physiol Endocrinol Metab 2002; 283:E1272-E1278.
24. Keller P, Penkowa M, Keller C, et al. Interleukin-6 receptor expression in contracting human skeletal muscle: regulating role of IL-6. FASEB J 2005; 19:1181-1183.
25. Phillips SM, Green HJ, Tarnopolsky MA, et al. Effects of training duration on substrate turnover and oxidation during exercise. J Appl Physiol 1996; 81:2182-2191.
26. Fischer CP, Berntsen A, Perstrup LB, et al. Plasma levels of interleukin-6 and C-reactive protein are associated with physical inactivity independent of obesity. Scand J Med Sci Sports; 2006. [Epub ahead of print]
27. Goldhammer E, Tanchilevitch A, Maor I, et al. Exercise training modulates cytokines activity in coronary heart disease patients. Int J Cardiol 2005; 100:93-99.
28. Kohut ML, McCann DA, Russell DW, et al. Aerobic exercise, but not flexibility/ resistance exercise, reduces serum IL-18, CRP, and IL-6 independent of beta-blockers, BMI, and psychosocial factors in older adults. Brain Behav Immun 2006; 20:201-209.
29. Fischer CP, Plomgaard P, Hansen AK, et al. Endurance training reduces the contraction-induced interleukin-6 mRNA expression in human skeletal muscle. Am J Physiol Endocrinol Metab 2004; 287:E1189-E1194.
30. Pedersen M, Steensberg A, Keller C, et al. Does the aging skeletal muscle maintain its endocrine function? Exerc Immunol Rev 2004; 10:42-55.
31. Keller C, Steensberg A, Hansen AK, et al. The effect of exercise, training, and glycogen availability on IL-6 receptor expression in human skeletal muscle. J Appl Physiol 2005; 99:2075-2079.
32. Jonsdottir IH, Schjerling P, Ostrowski K, et al. Muscle contractions induce interleukin-6 mRNA production in rat skeletal muscles. J Physiol 2000; 528:157-163.
33. Matsusaka T, Fujikawa K, Nishio Y, et al. Transcription factors NF-IL6 and NF-kappa B synergistically activate transcription of the inflammatory cytokines, interleukin 6 and interleukin 8. Proc Natl Acad Sci USA 1993; 90:10193-10197.
34. q-coupled receptor-induced interleukin-6 mRNA in vascular smooth muscle cells involves the nuclear factor of activated T cells. Mol Pharmacol 2000; 58:946-953.
35. Pritts TA, Hungness ES, Hershko DD, et al. Proteasome inhibitors induce heat shock response and increase IL-6 expression in human intestinal epithelial cells. Am J Physiol Regul Integr Comp Physiol 2002; 282:R1016-R1026.
36. Dolmetsch RE, Xu K, Lewis RS. Calcium oscillations increase the efficiency and specificity of gene expression. Nature 1998; 392:933-936.
37. 2+ transients activate calcineurin/ NFATc1 and initiate fast-to-slow transformation in a primary skeletal muscle culture. Am J Physiol Cell Physiol 2003; 285:C56-C63.
38. Chan MH, McGee SL, Watt MJ, et al. Altering dietary nutrient intake that reduces glycogen content leads to phosphorylation of nuclear p38 MAP kinase in human skeletal muscle: association with IL-6 gene transcription during contraction. FASEB J 2004; 18:1785-1787.
39. Keller C, Hellsten Y, Steensberg A, et al. Differential regulation of IL-6 and TNF-alpha via calcineurin in human skeletal muscle cells. Cytokine; 2006. [Epub ahead of print]
40. Banzet S, Koulmann N, Sanchez H, et al. Contraction-induced interleukin-6 transcription in rat slow-type muscle is partly dependent on calcineurin activation. J Cell Physiol 2007; 210:596-601.
41. McGee SL, Hargreaves M. Exercise and myocyte enhancer factor 2 regulation in human skeletal muscle. Diabetes 2004; 53:1208-1214.
42. Pilegaard H, Saltin B, Neufer PD. Exercise induces transient transcriptional activation of the PGC-1alpha gene in human skeletal muscle. J Physiol 2003; 546:851-858.
43. Ji LL, Gomez-Cabrera MC, Steinhafel N, et al. Acute exercise activates nuclear factor (NF)-kappaB signaling pathway in rat skeletal muscle. FASEB J 2004; 18:1499-1506.
44. Schreck R, Rieber P, Baeuerle PA. Reactive oxygen intermediates as apparently widely used messengers in the activation of the NF-kappa B transcription factor and HIV-1. EMBO J 1991; 10:2247-2258.
45. Davies KJ, Quintanilha AT, Brooks GA, et al. Free radicals and tissue damage produced by exercise. Biochem Biophys Res Commun 1982; 107:1198-1205.
46. Jackson MJ, Edwards RH, Symons MC. Electron spin resonance studies of intact mammalian skeletal muscle. Biochim Biophys Acta 1985; 847:185-190.
47. Bailey DM, Young IS, McEneny J, et al. Regulation of free radical outflow from an isolated muscle bed in exercising humans. Am J Physiol Heart Circ Physiol 2004; 287:H1689-H1699.
48. Kosmidou I, Vassilakopoulos T, Xagorari A, et al. Production of interleukin-6 by skeletal myotubes: role of reactive oxygen species. Am J Respir Cell Mol Biol 2002; 26:587-593.
49. Thompson D, Williams C, McGregor SJ, et al. Prolonged vitamin C supplementation and recovery from demanding exercise. Int J Sport Nutr Exerc Metab 2001; 11:466-481.
50. Vassilakopoulos T, Karatza MH, Katsaounou P, et al. Antioxidants attenuate the plasma cytokine response to exercise in humans. J Appl Physiol 2003; 94:1025-1032.
51. Jewitt DE, Reid D, Thomas M, et al. Free noradrenaline and adrenaline excretion in relation to the development of cardiac arrhythmias and heart failure in patients with acute myocardial infarction. Lancet 1969; 1:635-641.
52. Keller C, Steensberg A, Pilegaard H, et al. Transcriptional activation of the IL-6 gene in human contracting skeletal muscle: influence of muscle glycogen content. FASEB J 2001; 15:2748-2750.
53. Steensberg A, Van Hall G, Keller C, et al. Muscle glycogen content and glucose uptake during exercise in humans: influence of prior exercise and dietary manipulation. J Physiol 2002; 541:273-281.
54. Macdonald C, Wojtaszewski JFP, Pedersen BK, et al. Interleukin-6 release from human skeletal muscle during exercise: relation to AMPK activity. J Appl Physiol 2003; 95:2273-2327.
55. Febbraio MA, Steensberg A, Keller C, et al. Glucose ingestion attenuates interleukin-6 release from contracting skeletal muscle in humans. J Physiol 2003; 549:607-612.
56. Nehlsen-Cannarella SL, Fagoaga OR, Nieman DC, et al. Carbohydrate and the cytokine response to 2.5 h of running. J Appl Physiol 1997; 82:1662-1667.
57. Nieman DC, Nehlsen-Canarella SL, Fagoaga OR, et al. Influence of mode and carbohydrate on the cytokine response to heavy exertion. Med Sci Sports Exerc 1998; 30:671-678.
58. Starkie RL, Arkinstall MJ, Koukoulas I, et al. Carbohydrate ingestion attenuates the increase in plasma interleukin-6, but not skeletal muscle interleukin-6 mRNA, during exercise in humans. J Physiol 2001; 533:585-591.
59. Akerstrom TC, Birk JB, Klein DK, et al. Oral glucose ingestion attenuates exercise-induced activation of 5′-AMP-activated protein kinase in human skeletal muscle. Biochem Biophys Res Commun 2006; 342:949-955.
60. Ruderman NB, Keller C, Richard AM, et al. Interleukin-6 regulation of AMP-activated protein kinase: potential role in the systemic response to exercise and prevention of the metabolic syndrome. Diabetes 2006; 55 (Suppl 2):S48-S54.
61. Keller P, Keller C, Carey AL, et al. Interleukin-6 production by contracting human skeletal muscle: autocrine regulation by IL-6. Biochem Biophys Res Commun 2003; 319:550-554.
62. Montero-Julian FA, Klein B, Gautherot E, et al. Pharmacokinetic study of antiinterleukin-6 (IL-6) therapy with monoclonal antibodies: enhancement of IL-6 clearance by cocktails of anti-IL-6 antibodies. Blood 1995; 85:917-924.
63. Van Hall G, Steensberg A, Sacchetti M. Interleukin-6 stimulates lipolysis and fat oxidation in humans. J Clin Endocrinol Metab 2003; 88:3005-3010.
64. Febbraio MA, Ott P, Nielsen HB, et al. Hepatosplanchnic clearance of interleukin-6 in humans during exercise. Am J Physiol Endocrinol Metab 2003; 285:E397-E402.
65. Wojtaszewski JF, Jorgensen SB, Frosig C, et al. Insulin signalling: effects of prior exercise. Acta Physiol Scand 2003; 178:321-328.
66. Pedersen BK, Febbraio MA, Mooney RA. Interleukin-6 does/does not have a beneficial role in insulin sensitivity and glucose homeostasis. J Appl Physiol 2007; 102:814-816.
67. Febbraio MA, Hiscock N, Sacchetti M, et al. Interleukin-6 is a novel factor mediating glucose homeostasis during skeletal muscle contraction. Diabetes 2004; 53:1643-1648.
68. Steensberg A, Fischer CP, Sacchetti M, et al. Acute interleukin-6 administration does not impair muscle glucose uptake or whole body glucose disposal in healthy humans. J Physiol 2003; 548:631-638.
69. Lyngso D, Simonsen L, Bulow J. Interleukin-6 production in human subcutaneous abdominal adipose tissue: the effect of exercise. J Physiol 2002; 543:373-378.
70. Petersen EW, Carey AL, Sacchetti M, et al. Acute IL-6 treatment increases fatty acid turnover in elderly humans in vivo and in tissue culture in vitro: evidence that IL-6 acts independently of lipolytic hormones. Am J Physiol 2005; 288:E155-E162.
71. Carey AL, Steinberg GR, Macaulay SL, et al. IL-6 increases insulin stimulated glucose disposal in humans and glucose uptake and fatty acid oxidation in vitro via AMPK. Diabetes 2006; 55:2688-2697.
72. Kim HJ, Higashimori T, Park SY, et al. Differential effects of interleukin-6 and -10 on skeletal muscle and liver insulin action in vivo. Diabetes 2004; 53:1060-1067.
73. Ettinger MP, Littlejohn TW, Schwartz SL, et al. Recombinant variant of ciliary neurotrophic factor for weight loss in obese adults: a randomized, dose-ranging study. JAMA 2003; 289:1826-1832.
74. Nishimoto N, Yoshizaki K, Miyasaka N, et al. Treatment of rheumatoid arthritis with humanized antiinterleukin-6 receptor antibody: a multicenter, double-blind, placebo-controlled trial. Arthritis Rheum 2004; 50:1761-1769.
75. Atlizumab: anti-IL-6 receptor antibody-Chugai, antiinterleukin-6 receptor antibody-Chugai, MRA-Chugai. BioDrugs 2003; 17:369-372.
76. Choy EH, Isenberg DA, Garrood T, et al. Therapeutic benefit of blocking interleukin-6 activity with an antiinterleukin-6 receptor monoclonal antibody in rheumatoid arthritis: a randomized, double-blind, placebo-controlled, dose-escalation trial. Arthritis Rheum 2002; 46:3143-3150.
77. Wallenius V, Wallenius K, Ahren B, et al. Interleukin-6-deficient mice develop mature-onset obesity. Nat Med 2002; 8:75-79.
78. Stouthard JM, Oude Elferink RP, Sauerwein HP. Interleukin-6 enhances glucose transport in 3T3-L1 adipocytes. Biochem Biophys Res Commun 1996; 220:241-245.
79. Rotter V, Nagaev I, Smith U. Interleukin-6 (IL-6) induces insulin resistance in 3T3-L1 adipocytes and is, like IL-8 and tumor necrosis factor-alpha, overexpressed in human fat cells from insulin-resistant subjects. J Biol Chem 2003; 278:45777-45784.
80. Lagathu C, Bastard JP, Auclair M, et al. Chronic interleukin-6 (IL-6) treatment increased IL-6 secretion and induced insulin resistance in adipocyte: prevention by rosiglitazone. Biochem Biophys Res Commun 2003; 311:372-379.
81. Lyngso D, Simonsen L, Bulow J. Metabolic effects of interleukin-6 in human splanchnic and adipose tissue. J Physiol 2002; 543:379-386.
82. Al-Khalili L, Bouzakri K, Glund S, et al. Signaling specificity of interleukin-6 action on glucose and lipid metabolism in skeletal muscle. Mol Endocrinol 2006; 20:3364-3375.
83. Weigert C, Hennige AM, Brodbeck K, et al. Interleukin-6 (IL-6) acts as insulin sensitizer on glycogen synthesis in human skeletal muscle cells by phosphorylation of Ser-473 of Akt. Am J Physiol Endocrinol Metab 2005; 289:E251-E257.
84. Kahn BB, Alquier T, Carling D, et al. AMP-activated protein kinase: ancient energy gauge provides clues to modern understanding of metabolism. Cell Metab 2005; 1:15-25.
85. Kelly M, Keller C, Avilucea PR, et al. AMPK activity is diminished in tissues of the IL-6 knockout mice: the effect of exercise. Biochem Biophys Res Commun 2004; 320:449-454.
86. Bruce CR, Dyck DJ. Cytokine regulation of skeletal muscle fatty acid metabolism: effect of interleukin-6 and tumor necrosis factor-alpha. Am J Physiol Endocrinol Metab 2004; 287:E616-E621.
87. Watt MJ, Dzamko N, Thomas WG, et al. CNTF reverses obesity-induced insulin resistance by activating skeletal muscle AMPK. Nat Med 2006; 12:541-548.
88. Senn JJ, Klover PJ, Nowak IA, et al. Suppressor of cytokine signaling-3 (SOCS-3), a potential mediator of interleukin-6-dependent insulin resistance in hepatocytes. J Biol Chem 2003; 278:13740-13746.
89. Weigert C, Hennige AM, Lehmann R, et al. Direct cross-talk of interleukin-6 and insulin signal transduction via insulin receptor substrate-1 in skeletal muscle cells. J Biol Chem 2006; 281:7060-7067.
90. Starkie R, Ostrowski SR, Jauffred S, et al. Exercise and IL-6 infusion inhibit endotoxin-induced TNF-alpha production in humans. FASEB J 2003; 17:884-886.
91. Plomgaard P, Bouzakri K, Krogh-Madsen R, et al. TNF-alpha induces skeletal muscle insulin resistance in healthy human subjects via inhibition of AS160 phosphorylation. Diabetes 2005; 54:2939-2945.
92. Mohr T, Andersen JL, Biering-Sorensen F, et al. Long-term adaptation to electrically induced cycle training in severe spinal cord injured individuals. Spinal Cord 1997; 35:1-16.
93. Kjaer M, Secher NH, Bangsbo J, et al. Hormonal and metabolic responses to electrically induced cycling during epidural anesthesia in humans. J Appl Physiol 1996; 80:2156-2162.
94. Asmussen E. Exercise: general statement of unsolved problems. Circ Res 1967; 20:12-15.
95. Keller C, Keller P, Marshall-Gradisnik SM, et al. IL-6 gene expression in human adipose tissue in response to exercise - effect of carbohydrate ingestion. J Physiol 2003; 550:927-931.
96. Nehlsen-Canarella SL, Fagoaga OR, Nieman DC. Carbohydrate and the cytokine response to 2.5 h of running. J Appl Physiol 1997; 82:1662-1667.
97. Starkie RL, Arkinstall MJ, Koukoulas I, et al. Carbohydrate ingestion attenuates the increase in plasma interleukin-6, but not skeletal muscle interleukin-6 mRNA, during exercise in humans. J Physiol 2001; 533:585-591.
98. Rhind SG, Gannon GA, Shephard RJ, et al. Indomethacin modulates circulating cytokine responses to strenuous exercise in humans. Cytokine 2002; 19:153-158.
99. Holmes AG, Watt MJ, Febbraio MA. Suppressing lipolysis increases interleukin-6 at rest and during prolonged moderate-intensity exercise in humans. J Appl Physiol 2004; 97:689-696.
100. Starkie RL, Hargreaves M, Rolland J, et al. Heat stress, cytokines, and the immune response to exercise. Brain Behav Immun 2005; 19:404-412.